Loading company…
Zymergen is an Emeryville, US biotechnology company using biology and technology to develop materials and products.
Founded in 2013 in Emeryville, US, Zymergen is a biotechnology company that develops materials and products through genetic engineering and biological processes, serving agricultural and pharmaceutical clients. It went public on April 21, 2021, raising USD 500.03 mn, and was acquired by Ginkgo BioWorks, Inc. in July 2022 for an undisclosed amount. In 2021 it reported revenue of USD 16.74 mn and an EBITDA loss of USD 326.87 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in